SavedAdd your journal

Journals / Türk Kardiyoloji Derneği Arşivi / 2017 / Cilt: 45 - Sayı: 7

Stent and implantable cardioverter defibrillator implantation in medically resistant vasospastic angina patient

İlaca dirençli vazospastik anginalı hastada stent ve implante edilebilir defibrilatör tedavisi

Nil ÖZYÜNCÜ
Onur YILDIRIM
Türkan Seda Tan KÜRKLÜ
Hüseyin GÖKSÜLÜK
Veysel Kutay VURGUN
Pages
641–645
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

An implantable cardioverter defibrillator was also implanted for secondary prevention of ventricular arrhythmia, as vasospasm was considered to be a diffuse disease without a certain definitive treatment

📌 3 Key Takeaways

🎯
Objective & Hypothesis:– Vasospastic angina, also known as Prinzmetal’s angina, is thought to occur due to vascular hyper-reactivity to various stimuli.
📊
Key Findings & Data:Response to medical therapy is usually good; however, 1 out of 5 patients has resistant symptoms.
💡
Conclusion & Impact:An implantable cardioverter defibrillator was also implanted for secondary prevention of ventricular arrhythmia, as vasospasm was considered to be a diffuse disease without a certain definitive treatment
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

– Vasospastic angina, also known as Prinzmetal’s angina, is thought to occur due to vascular hyper-reactivity to various stimuli. Response to medical therapy is usually good; however, 1 out of 5 patients has resistant symptoms. Rarely, potentially lethal arrhythmias can occur due to vasospasm, and those patients are reported to have a poorer prognosis. Presently described is a case of resistant vasospastic angina with persistent symptoms under calcium channel blocker and nitrate treatment. The patient presented with hemodynamically unstable rapid-rate ventricular tachycardia, which was quite resistant to recurrent cardioversion. She was treated with stent implantation for definite vasospastic segments of the coronaries, in combination with medical therapy. An implantable cardioverter defibrillator was also implanted for secondary prevention of ventricular arrhythmia, as vasospasm was considered to be a diffuse disease without a certain definitive treatment

Özet

- Prinzmetal angina olarak da bilinen vazospastik an- gina, birçok faktörün tetikleyebileceği bir damar aşırı duyar- lılığı olarak düşünülmektedir. Tıbbi tedaviye yanıt sıklıkla iyidir, ancak her beş hastadan birinde dirençli semptomlar görülmektedir. Nadiren vazospazma bağlı ölümcül aritmiler görülebilmektedir ve bu hastalarda prognoz daha kötüdür. Burada, kalsiyum kanal blokeri ve nitrat tedavisine rağmen semptomları devam eden dirençli bir vazospastik anginalı olguyu sunduk. Hasta, hemodinamik bozukluğa yol açan ve tekrarlayan kardiyoversiyonlara dirençli yüksek hızlı ventri- küler taşikardi ile başvurdu. Tıbbi tedavisine ek olarak, ko- ronerlerdeki belirgin vazospastik segmentlere stent yerleş- tirilerek tedavi edildi. Ayrıca, vazospazm kesin bir tedavisi olmayan yaygın bir vasküler hastalık olduğundan, ventrikül aritmilerine karşı ikincil korunma amaçlı implante edilebilir defibrilatör yerleştirildi

🔖

Cite This Article

ÖZYÜNCÜ, N., YILDIRIM, O., KÜRKLÜ, T. S. T., GÖKSÜLÜK, H., VURGUN, V. K. (2022). Stent and implantable cardioverter defibrillator implantation in medically resistant vasospastic angina patient. Türk Kardiyoloji Derneği Arşivi, Cilt: 45 - Sayı: 7, 641–645. https://ajindex.com/articles/633351

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Eschalier R, Souteyrand G, Jean F, Roux A, Combaret N, Sa- ludas Y, et al. Should an implanted defibrillator be considered in patients with vasospastic angina? Arch Cardiovasc Dis 2014;107:42–7.
  2. Bory M, Pierron F, Panagides D, Bonnet JL, Yvorra S, Des- fossez L. Coronary artery spasm in patients with normal or near normal coronary arteries. Long-term follow-up of 277 patients. Eur Heart J 1996;17:1015–21.
  3. Takagi Y, Yasuda S, Tsunoda R, Ogata Y, Seki A, Sumiyoshi T, et al. Japanese Coronary Spasm Association. Clinical char- acteristics and long-term prognosis of vasospastic angina pa- tients who survived out-of-hospital cardiac arrest: multicenter registry study of the Japanese Coronary Spasm Association. Circ Arrhythm Electrophysiol 2011;4:295–302.
  4. Gaspardone A, Tomai F, Versaci F, Ghini AS, Polisca P, Crea F, et al. Coronary artery stent placement in patients with vari- ant angina refractory to medical treatment. Am J Cardiol 1999;84:96–8.
  5. Chu G, Zhang G, Zhang Z, Liu S, Wen Q, Sun B. Clinical outcome of coronary stenting in patients with variant angina refractory to medical treatment: a consecutive single-center analysis. Med Princ Pract 2013;22:583–7. JCS Joint Working Group. Guidelines for diagnosis and treat- ment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013). Circ J 2014;78:2779–801.
  6. Takagi Y, Takahashi J, Yasuda S, Miyata S, Tsunoda R, Ogata Y, Seki A, et al. Japanese Coronary Spasm Associa- tion. Prognostic stratification of patients with vasospastic an- gina: a comprehensive clinical risk score developed by the Japanese Coronary Spasm Association. J Am Coll Cardiol 2013;62:1144–53.
  7. Matsue Y, Suzuki M, Nishizaki M, Hojo R, Hashimoto Y, Sakurada H. Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic an- gina and lethal ventricular arrhythmia. J Am Coll Cardiol 2012;60:908,13. Ahn JM, Lee KH, Yoo SY, Cho YR, Suh J, Shin ES, et al. Prognosis of Variant Angina Manifesting as Aborted Sudden Cardiac Death. J Am Coll Cardiol 2016;68:137–45.
  8. Meisel SR, Mazur A, Chetboun I, Epshtein M, Canetti M, Gallimidi J, et al. Usefulness of implantable cardioverter-de- fibrillators in refractory variant angina pectoris complicated by ventricular fibrillation in patients with angiographically normal coronary arteries. Am J Cardiol 2002;89:1114–6.
  9. Al-Sayegh A, Shukkur AM, Akbar M. Automatic implantable cardioverter defibrillator for the treatment of ventricular fibril- lation following coronary arter